Thomas P Miller

  • 19247 Citations
  • 57 h-Index
1978 …2016

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

External beam radiation therapy in the treatment of patients with extranodal stage IA non-Hodgkin's lymphoma

Briggs, J. H., Algan, Ö., Miller, T. P. & Oleson, J. R., Feb 18 2002, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 25, 1, p. 34-37 4 p.

Research output: Contribution to journalArticle

7 Scopus citations

Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone

Persky, D. O., Dornan, D., Goldman, B. H., Braziel, R. M., Fisher, R. I., LeBlanc, M., Maloney, D. G., Press, O. W., Miller, T. P. & Rimsza, L. M., Jun 1 2012, In : Haematologica. 97, 6, p. 937-942 6 p.

Research output: Contribution to journalArticle

44 Scopus citations

Follicular lymphomas: Do histologic subtypes predict outcome?

Miller, T. P., LeBlanc, M., Grogan, T. M., Fisher, R. I. & Graff, J. C., Jan 1 1997, In : Hematology/Oncology Clinics of North America. 11, 5, p. 893-900 8 p.

Research output: Contribution to journalArticle

43 Scopus citations

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP

Rimsza, L. M., LeBlanc, M. L., Unger, J. M., Miller, T. P., Grogan, T. M., Persky, D. O., Mattel, R. R., Sabalos, C. M., Seligmann, B., Braziel, R. M., Campo, E., Rosenwald, A., Connors, J. M., Sehn, L. H., Johnson, N. & Gascoyne, R. D., Oct 15 2008, In : Blood. 112, 8, p. 3425-3433 9 p.

Research output: Contribution to journalArticle

111 Scopus citations

Gene expression profile of serial samples of transformed B-cell lymphomas

De Vos, S., Hofmann, W. K., Grogan, T. M., Krug, U., Schrage, M., Miller, T. P., Braun, J. G., Wachsman, W., Koeffler, H. P. & Said, J. W., Feb 1 2003, In : Laboratory Investigation. 83, 2, p. 271-285 15 p.

Research output: Contribution to journalArticle

Open Access
94 Scopus citations

Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma

Gustafson, H. L., Yao, S., Goldman, B. H., Lee, K., Spier, C. M., LeBlanc, M. L., Rimsza, L. M., Cerhan, J. R., Habermann, T. M., Link, B. K., Maurer, M. J., Slager, S. L., Persky, D. O., Miller, T. P., Fisher, R. I., Ambrosone, C. B. & Briehl, M. M., May 2014, In : American Journal of Hematology. 89, 6, p. 639-645 7 p.

Research output: Contribution to journalArticle

18 Scopus citations

HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma

Miller, T. P., Lippman, S. M., Spier, C. M., Slymen, D. J. & Grogan, T. M., Jan 1 1988, In : Journal of Clinical Investigation. 82, 1, p. 370-372 3 p.

Research output: Contribution to journalArticle

Open Access
73 Scopus citations

Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313

Persky, D. O., Miller, T. P., Unger, J. M., Spier, C. M., Puvvada, S., Dino Stea, B., Press, O. W., Constine, L. S., Barton, K. P., Friedberg, J. W., LeBlanc, M. & Fisher, R. I., Aug 8 2015, In : Blood. 125, 2, p. 236-241 6 p.

Research output: Contribution to journalArticle

6 Scopus citations

Immunobiologic correlates of prognosis in lymphoma

Grogan, T. M. & Miller, T. P., Jan 1 1993, In : Seminars in Oncology. 20, SUPPL. 5, p. 58-74 17 p.

Research output: Contribution to journalReview article

11 Scopus citations

Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma

Slymen, D. J., Miller, T. P., Lippman, S. M., Spier, C. M., Kerrigan, D. P., Rybski, J. A., Rangel, C. S., Richter, L. C. & Grogan, T. M., Jan 1 1990, In : Journal of Clinical Oncology. 8, 6, p. 986-993 8 p.

Research output: Contribution to journalArticle

47 Scopus citations

Immunologic complexity of lymphoblastic lymphoma

Grogan, T., Spier, C., Wirt, D. P., Hicks, M. J., Paquin, M., Hutter, J., Miller, T., Rangel, C., Richter, L. & Jones, S., Jul 16 1986, In : Diagnostic immunology. 4, 2, p. 81-88 8 p.

Research output: Contribution to journalArticle

20 Scopus citations

Immunotopographic assessment of lymphoid and plasma cell malignancies in the bone marrow

Kronland, R., Grogan, T., Spier, C., Wirt, D., Rangel, C., Richter, L., Durie, B., Greenberg, B., Miller, T. & Jones, S., Dec 1985, In : Human pathology. 16, 12, p. 1247-1254 8 p.

Research output: Contribution to journalArticle

12 Scopus citations

Immunotyping malignant lymphomas. A boon to diagnosis.

Grogan, T. M., Spier, C. M. & Miller, T. P., Sep 1 1986, In : Cleveland Clinic Quarterly. 53, 3, p. 315-317 3 p.

Research output: Contribution to journalArticle

Improved survival for patients with advanced non-small-cell carcinoma of the lung

Miller, T. P., Dec 1 1979, In : Arizona Medicine. 36, 12, p. 893-897 5 p.

Research output: Contribution to journalArticle

Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67

Grogan, T. M., Lippman, S. M., Spier, C. M., Slymen, D. J., Rybski, J. A., Rangel, C. S., Richter, L. C. & Miller, T. P., Jan 1 1988, In : Blood. 71, 4, p. 1157-1160 4 p.

Research output: Contribution to journalArticle

184 Scopus citations

Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: A Southwest Oncology Group Study

Gaynor, E. R., Unger, J. M., Miller, T. P., Grogan, T. M., White, J., Mills, G. M., Balcerzak, S. P., Varterasian, M., LeBlanc, M. & Fisher, R. I., Feb 1 2001, In : Journal of Clinical Oncology. 19, 3, p. 750-755 6 p.

Research output: Contribution to journalArticle

27 Scopus citations

Initial chemotherapy for clinically localized lymphomas of unfavorable histology

Miller, T. P. & Jones, S. E., Jan 1 1983, In : Blood. 62, 2, p. 413-418 6 p.

Research output: Contribution to journalArticle

150 Scopus citations

In Reply [2]

Miller, T. P. & Grogan, T. M., Dec 1 2005, In : Journal of Clinical Oncology. 23, 35, p. 9030-9031 2 p.

Research output: Contribution to journalLetter

Interferon alfa consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non- Hodgkin's lymphoma: Results of the Southwest Oncology Group randomized phase III study 8809

Fisher, R. I., Dana, B. W., LeBlanc, M., Kjeldsberg, C., Forman, J. D., Unger, J. M., Balcerzak, S. P., Gaynor, E. R., Roy, V. & Miller, T., May 2000, In : Journal of Clinical Oncology. 18, 10, p. 2010-2016 7 p.

Research output: Contribution to journalArticle

75 Scopus citations

Interferon does not prolong progression-free survival after ProMACE-MOPP [5] (multiple letters)

Cabanillas, F., Fisher, R. I., Leblanc, M. & Miller, T., Sep 15 2000, In : Journal of Clinical Oncology. 18, 18, 1 p.

Research output: Contribution to journalLetter

Is there a role for radiotherapy in localized diffuse lymphomas?

Miller, T. P. & Jones, S. E., May 1980, In : Cancer Chemotherapy And Pharmacology. 4, 2, p. 67-70 4 p.

Research output: Contribution to journalEditorial

15 Scopus citations

Lennert's lymphoma: A clinicopathologic study with emphasis on phenotype and its relationship to survival

Spier, C. M., Lippman, S. M., Miller, T. P. & Grogan, T. M., Feb 1 1988, In : Cancer. 61, 3, p. 517-524 8 p.

Research output: Contribution to journalArticle

23 Scopus citations

Leukocyte concentrations in discrimination of benign from malignant lung lesions

Thomson, S. P., Kessler, J. F. & Miller, T. P., Jun 1986, In : The American journal of medicine. 80, 6, p. 1035-1040 6 p.

Research output: Contribution to journalArticle

12 Scopus citations

Localized large cell lymphoma: Is there any need for radiation therapy?

Persky, D. O. & Miller, T. P., Sep 1 2009, In : Current Opinion in Oncology. 21, 5, p. 401-406 6 p.

Research output: Contribution to journalReview article

18 Scopus citations
97 Scopus citations

Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy

Dana, B. W., Dahlberg, S., Nathwani, B. N., Chase, E., Coltman, C., Miller, T. P. & Fisher, R. I., Jan 1 1993, In : Journal of Clinical Oncology. 11, 4, p. 644-651 8 p.

Research output: Contribution to journalArticle

185 Scopus citations

Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas

Fisher, R. I., Longo, D. L., DeVita, V. T., Hubbard, S. M., Miller, T. P. & Young, R. C., Jan 1 1991, In : Annals of Oncology. 2, SUPPL. 1, p. 33-35 3 p.

Research output: Contribution to journalArticle

Open Access
27 Scopus citations

Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma

Stopeck, A. T., Gessner, A., Miller, T. P., Hersh, E. M., Johnson, C. S., Cui, H., Frutiger, Y. & Grogan, T. M., Jan 1 2000, In : Clinical Cancer Research. 6, 10, p. 3904-3909 6 p.

Research output: Contribution to journalArticle

57 Scopus citations

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions

Rimsza, L. M., Roberts, R. A., Campo, E., Grogan, T. M., Bea, S., Salaverria, I., Zettl, A., Rosenwald, A., Ott, G., Muller-Hermelink, H. K., Delabie, J., Fisher, R. I., Unger, J. M., LeBlanc, M., Staudt, L. M., Jaffe, E. S., Gascoyne, R. D., Chan, W. C., Weisenburger, D. D., Greiner, T. & 2 others, Braziel, R. M. & Miller, T. P., Feb 1 2006, In : Blood. 107, 3, p. 1101-1107 7 p.

Research output: Contribution to journalArticle

54 Scopus citations

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival

Roberts, R. A., Wright, G., Rosenwald, A. R., Jaramillo, M. A., Grogan, T. M., Miller, T. P., Frutiger, Y., Chan, W. C., Gascoyne, R. D., Ott, G., Muller-Hermelink, H. K., Staudt, L. M. & Rimsza, L. M., Jul 1 2006, In : Blood. 108, 1, p. 311-318 8 p.

Research output: Contribution to journalArticle

67 Scopus citations

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: A follow-up study from the Leukemia and Lymphoma Molecular Profiling Project

Rimsza, L. M., Roberts, R. A., Miller, T. P., Unger, J. M., LeBlanc, M., Braziel, R. M., Weisenberger, D. D., Chan, W. C., Muller-Hermelink, H. K., Jaffe, E. S., Gascoyne, R. D., Campo, E., Fuchs, D. A., Spier, C. M., Fisher, R. I., Delabie, J., Rosenwald, A., Staudt, L. M. & Grogan, T. M., Jun 1 2004, In : Blood. 103, 11, p. 4251-4258 8 p.

Research output: Contribution to journalArticle

216 Scopus citations

Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease: A Southwest Oncology Group randomized study

Fabian, C. J., Mansfield, C. M., Dahlberg, S., Jones, S. E., Miller, T. P., Van Slyck, E., Grozea, P. N., Morrison, F. S., Coltman, C. A. & Fisher, R. I., Jun 1 1994, In : Annals of internal medicine. 120, 11, p. 903-912 10 p.

Research output: Contribution to journalArticle

150 Scopus citations

Management of intermediate-grade lymphomas

Miller, T. P., Dec 5 1998, In : ONCOLOGY. 12, 10 SUPPL. 8, p. 35-39 5 p.

Research output: Contribution to journalReview article

6 Scopus citations

m-BACOD Treatment for intermediate- and high-grade malignant lymphomas: A Southwest Oncology Group phase II trial

Dana, B. W., Dahlberg, S., Miller, T. P., Hartsock, R. J., Balcerzak, S., Coltman, C. A., Carden, J. O., Hartley, K. & Fisher, R. I., Jan 1 1990, In : Journal of Clinical Oncology. 8, 7, p. 1155-1162 8 p.

Research output: Contribution to journalArticle

47 Scopus citations

Mistaken clinical and pathologic diagnoses of Hodgkin's disease: A Southwest Oncology Group Study

Miller, T. P., Byrne, G. E. & Jones, S. J., Jan 1 1982, In : Cancer Treatment Reports. 66, 4, p. 645-651 7 p.

Research output: Contribution to journalArticle

29 Scopus citations

Mitotic counts in follicular lymphomas

Ellison, D. J., Nathwani, B. N., Metter, G. E., Turner, R. R., Burke, J. S., Miller, T. P., Mann, R. B., Barcos, M., Kjeldsberg, C. R., Winberg, C. D. & Whitcomb, C. C., May 1987, In : Human pathology. 18, 5, p. 502-505 4 p.

Research output: Contribution to journalArticle

16 Scopus citations

Molecular diagnosis of Burkitt's lymphoma

Dave, S. S., Fu, K., Wright, G. W., Lam, L. T., Kluin, P., Boerma, E. J., Greiner, T. C., Weisenburger, D. D., Rosenwald, A., Ott, G., Müller-Hermelink, H. K., Gascoyne, R. D., Delabie, J., Rimsza, L. M., Braziel, R. M., Grogan, T. M., Campo, E., Jaffe, E. S., Dave, B. J., Sanger, W. & 18 others, Bast, M., Vose, J. M., Armitage, J. O., Connors, J. M., Smeland, E. B., Kvaloy, S., Holte, H., Fisher, R. I., Miller, T. P., Montserrat, E., Wilson, W. H., Bahl, M., Zhao, H., Yang, L., Powell, J., Simon, R., Chan, W. C. & Staudt, L. M., Jun 8 2006, In : New England Journal of Medicine. 354, 23, p. 2431-2442 12 p.

Research output: Contribution to journalArticle

648 Scopus citations

Mood alterations in patients treated with chlorambucil

Hehn, S. T., Dorr, R. T. & Miller, T. P., Dec 2003, In : Clinical Lymphoma. 4, 3, p. 179-182 4 p.

Research output: Contribution to journalArticle

4 Scopus citations

Morphological subclassification of follicular lymphoma: Variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies

Metter, G. E., Nathwani, B. N., Burke, J. S., Winberg, C. D., Mann, R. B., Barcos, M., Kjeldsberg, C. R., Whitcomb, C. C., Dixon, D. O. & Miller, T. P., Jan 1 1985, In : Journal of Clinical Oncology. 3, 1, p. 25-38 14 p.

Research output: Contribution to journalArticle

97 Scopus citations

Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease

Silver, R. T., Case, D. C., Wheeler, R. H., Miller, T. P., Stein, R. S., Stuart, J. J., Peterson, B. A., Rivkin, S. E., Golomb, H. M., Costanzi, J. J., Erslev, A. J., Reisman, A. & Dugan, M., Jan 1 1991, In : Journal of Clinical Oncology. 9, 5, p. 754-761 8 p.

Research output: Contribution to journalArticle

44 Scopus citations

Multidrug-resistant myeloma: Laboratory and clinical effects of verapamil as a chemosensitizer

Salmon, S. E., Dalton, W. S., Grogan, T. M., Plezia, P., Lehnert, M., Roe, D. J. & Miller, T. P., Jan 1 1991, In : Blood. 78, 1, p. 44-50 7 p.

Research output: Contribution to journalArticle

209 Scopus citations

Natural history of cns relapse in patients with aggressive non-hodgkin's lymphoma: A 20-year follow-up analysis of swog 8516-the southwest oncology group

Bernstein, S. H., Unger, J. M., LeBlanc, M., Friedberg, J., Miller, T. P. & Fisher, R. I., Jan 1 2009, In : Journal of Clinical Oncology. 27, 1, p. 114-119 6 p.

Research output: Contribution to journalArticle

138 Scopus citations

NCAM (CD56)-positive malignant lymphoma

Kern, W. F., Spier, C. M., Miller, T. P. & Grogan, T. M., Jan 1 1993, In : Leukemia and Lymphoma. 12, 1-2, p. 1-10 10 p.

Research output: Contribution to journalArticle

40 Scopus citations

Neural cell adhesion molecule-positive peripheral T-cell lymphoma: A rare variant with a propensity for unusual sites of involvement

Kern, W. F., Spier, C. M., Hanneman, E. H., Miller, T. P., Matzner, M. & Grogan, T. M., Jan 1 1992, In : Blood. 79, 9, p. 2432-2437 6 p.

Research output: Contribution to journalArticle

216 Scopus citations

New biologic markers in non-Hodgkin's lymphomas

Grogan, T. M. & Miller, T. P., Jan 1 1991, In : Hematology/Oncology Clinics of North America. 5, 5, p. 925-933 9 p.

Research output: Contribution to journalReview article

5 Scopus citations

New REAL clinical entities

Fisher, R. I., Miller, T. P. & Grogan, T. M., Jul 29 1998, In : Cancer Journal from Scientific American. 4, SUPPL. 2, p. S5-S12

Research output: Contribution to journalArticle

12 Scopus citations

New treatment options have changed the survival of patients with follicular lymphoma

Fisher, R. L., LeBlanc, M., Press, O. W., Maloney, D. G., Unger, J. M. & Miller, T. P., Dec 1 2005, In : Journal of Clinical Oncology. 23, 33, p. 8447-8452 6 p.

Research output: Contribution to journalArticle

332 Scopus citations

Patients with localized non-Hodgkin's lymphomas provide opportunities for future research

Miller, T. P. & Grogan, T. M., Jan 1 1991, In : ONCOLOGY. 5, 8, p. 127-132 6 p.

Research output: Contribution to journalArticle

3 Scopus citations

Peripheral T-cell lymphoma: Aggressive disease with heterogeneous immunotypes

Grogan, T. M., Fielder, K., Rangel, C., Jolley, C. J., Wirt, D. P., Hicks, M. J., Miller, T. P., Brooks, R., Greenberg, B. & Jones, S., Jan 1 1985, In : American journal of clinical pathology. 83, 3, p. 279-288 10 p.

Research output: Contribution to journalArticle

119 Scopus citations